Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,100
-60 (-0.59%)
Sep 11, 2026, 3:30 PM KST

KRX:271980 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
58,54148,87453,47632,99131,44625,963
Short-Term Investments
4,4104,2693,9802,667142.462,040
Trading Asset Securities
4,4565,689----
Cash & Short-Term Investments
67,40758,83257,45535,65831,58928,003
Cash Growth
26.13%2.40%61.13%12.88%12.80%325.06%
Accounts Receivable
146,534136,848160,467150,955137,807129,424
Other Receivables
5,4654,13613,44015,17115,45415,265
Receivables
151,999140,984173,908166,126153,262146,689
Inventory
102,891104,475104,427109,76899,151102,458
Prepaid Expenses
283.82515.62214.62327.84291.88186.71
Other Current Assets
7,6656,8167,0315,1677,3487,336
Total Current Assets
330,246311,621343,036317,046291,641284,672
Property, Plant & Equipment
153,876147,726146,166137,041138,402125,710
Long-Term Investments
11,73325,0168,3427,3436,7985,032
Other Intangible Assets
9,2708,8544,9944,3203,8883,762
Long-Term Accounts Receivable
0-00-000
Long-Term Deferred Tax Assets
13,8459,2597,4285,359172.391,452
Long-Term Deferred Charges
5,6856,5838,3788,5615,494-
Other Long-Term Assets
1,4621,5157,3567,65610,4965,858
Total Assets
526,117510,575525,700487,326456,892426,486

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
70,08189,019134,562144,338151,641153,084
Accrued Expenses
229.67170.84178.21160.7499.9129.33
Short-Term Debt
104,14790,48771,00064,77240,57624,166
Current Portion of Long-Term Debt
----2,5006,125
Current Portion of Leases
2,1501,8451,9711,9461,8321,915
Current Income Taxes Payable
266.491,7943,588448.241,049114.57
Other Current Liabilities
71,56459,13780,39192,71062,66736,509
Total Current Liabilities
248,438242,454291,690304,375260,366221,943
Long-Term Debt
5,500---3,9998,977
Long-Term Leases
480.251,0842,7254,4525,4436,617
Pension & Post-Retirement Benefits
18,34115,91811,7716,73325.041,262
Other Long-Term Liabilities
94.1194.11197.01938.5223,17020,339
Total Liabilities
272,854259,549306,383316,499293,003259,139

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
7,3527,3527,3527,3527,3527,352
Additional Paid-In Capital
204,746206,399206,223155,296155,296155,296
Retained Earnings
-37,663-29,336-52,296-19,660-20,321-10,414
Treasury Stock
--4,829-4,829-4,829-4,829-4,432
Comprehensive Income & Other
31,37931,48431,69920,41020,41020,410
Total Common Equity
205,815211,071188,150158,570157,909168,213
Minority Interest
47,44839,95431,167-1,538-2,312-866.16
Shareholders' Equity
253,263251,025219,317170,828163,889167,347
Total Liabilities & Equity
526,117510,575525,700487,326456,892426,486

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
112,27793,41675,69571,17054,35047,800
Net Cash (Debt)
-44,870-34,585-18,240-35,513-22,761-19,797
Net Cash Growth
------
Net Cash Per Share
-3069.44-2373.44-1252.00-2437.13-1561.68-1355.11
Filing Date Shares Outstanding
14.7114.5714.5714.5714.5714.58
Total Common Shares Outstanding
14.7114.5714.5714.5714.5714.58
Working Capital
81,80869,16851,34512,67131,27562,729
Book Value Per Share
13990.4014485.2012912.1610882.2010836.8311533.52
Tangible Book Value
196,545202,217183,156154,250154,021164,451
Tangible Book Value Per Share
13360.2913877.5812569.4410585.7110570.0211275.56
Land
56,74954,46153,69840,61340,58630,106
Buildings
66,721107,964105,484103,864103,864102,213
Machinery
8,97293,16488,78788,62282,31576,560
Construction In Progress
-6,0824,7243,0703,7172,390